Body Composition Research — for in-vitro research and laboratory use only

Metabolic

Two of the most-studied metabolic peptides combined.

Retatrutide is a triple-agonist (GLP-1, GIP, glucagon) — the first peptide to target all three receptors in a single molecule. Pair it with Cagrilintide (an amylin analogue) and you're covering the two primary metabolic research pathways.

All research stacks · Research hub · Certificates of Analysis

For research use only. Not for human consumption.